Pulmonary Hypertension Observational Study

NCT05958901 · tracked via the Priya Life Science China tracker

Sponsor

The First Affiliated Hospital of Guangzhou Medical University

Phase

Observational

Started

2023-07-12

Last updated

2023-07-25

Condition(s) studied

Pulmonary Hypertension

Investigational drug(s) / intervention(s)

pulmonary hypertension

pulmonary hypertension: The final outcome observed was a diagnosis of pulmonary hypertension.

Study summary

The purpose of this study is to establish the large PH cohort and biological database in China, aiming for precision medicine to optimize diagnosis and treatment choices.

Eligibility

Sex

ALL

Min age

20 Years

Max age

70 Years

Healthy volunteers

Accepted

Inclusion Criteria: * PH group: When the mean pulmonary artery pressure is greater than 25mmHg at rest or greater than 30mmHg during exercise. * Signed informed consent obtained prior to participations with the ability to comply with protocol and be available for study visits over 5 years. Exclusion Criteria: * Acute exacerbation in the past 3 months Having other respiratory diseases with massive lung tissue destruction such as severe bronchiectasis and tuberculosis, etc. * Serious uncontrolled diseases thoracic or abdominal surgery in the last 3 months. * Eye surgery in the last three months. * Retinal detachment myocardial infarction in the last 3 months. * Admission to hospital for any cardiac condition in the last month. * Heart rate over 120 beats per minute. * Antibacterial chemotherapy for tuberculosis pregnant or breast feeding.

Primary outcome measure(s)

mean pulmonary arterial pressure — 12 months
For an adult at sea level, when the mean pulmonary arterial pressure is greater than 25 mmHg at rest or greater than 30mmHg during exercise.

Trial sites (1)

Facility	City	Region	Status
The First Affiliated Hospital of Guangzhou Medical University	Guangzhou	Guangdong	Recruiting

More The First Affiliated Hospital of Guangzhou Medical University trials in China

China Chronic Cough Registry: a Multicenter, Prospective, Observational Study Starting soon

Nebulized Inhalation of Recombinant Human p53 Adenovirus Injection for Treatment of Multiple Ground-Glass Lung Nodules: A Single-Arm Clinical Study Starting soon

Tubeless Strategy for Enhanced Recovery After Sublobar Resection Starting soon

The Effect of Different Body Positions and Channel Sheaths on RIRS Recruiting

Predictive Value of Preoperative Urine Culture for Postoperative Fever After FANS-RIRS When Surgery Proceeds Before Culture Results Are Available Active, not recruiting

Other trials for the same condition

Continuous Effect Of Rehabilitation Training On Pulmonary Arterial Hypertension Patients Recruiting

CHASE Registry of Patients With Pulmonary Hypertension Receiving Targeted Therapy Recruiting

Safety Surveillance of Targeted Drugs for Pulmonary Hypertension Using a Computerized Follow-up System: a Nationwide Cohort Study Recruiting

Registration Study for Rare Type of Pulmonary Hypertension Recruiting

A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05958901 on ClinicalTrials.gov ↗ ← All trials in China